
Best CGM for Type 2 Diabetes in 2026: Prescription and OTC Options
Type 2 diabetes accounts for 90 to 95% of all diabetes cases, affecting 37.3 million Americans. Continuous glucose monitors help T2D patients understand how specific foods, medications, and activities affect blood sugar in real time, providing insights that 2 to 4 daily fingerstick tests cannot deliver. The MOBILE study published in JAMA demonstrated that CGM use in T2D patients on basal insulin improved A1C by 0.4% and increased time in the target glucose range by 3.6 hours per day.
The best CGM for type 2 diabetes depends on treatment intensity. Patients on insulin therapy benefit from prescription CGMs with real-time alerts — the FreeStyle Libre 3 Plus offers the best combination of accuracy (7.9% MARD), affordability ($15 to $30/month with insurance), and 15-day wear time. For T2D patients not on insulin, over-the-counter options like the Dexcom Stelo ($49 to $99/month) and Abbott Lingo ($49/month) provide glucose pattern insights without a prescription. Medicare now covers CGMs for all insulin-using T2D patients, making the Dexcom G7 and Libre 3 Plus accessible to seniors managing type 2 diabetes.

The FreeStyle Libre 3 Plus is the top overall pick for type 2 diabetes because it delivers best-in-class accuracy at the lowest insured cost, with Medicare coverage for qualifying patients. Non-insulin T2D patients should consider the Abbott Lingo for its $49/month price point and metabolism-focused app. Patients on intensive insulin therapy who need pump integration should choose the Dexcom G7.
Recommended CGMs for This Category
| Product | MARD | Wear Time | Type | Rx? | With Insurance | Without Insurance | Medicare | Rating |
|---|---|---|---|---|---|---|---|---|
| Dexcom G7 | 8.2% | 10 days | Real time CGM | Yes | $20–$40 per month | $250–$350 per month | ✓ | 4.8 |
| Dexcom G7 15-Day | 8.2% | 15 days | Real time CGM | Yes | $20–$40 per month | $250–$350 per month | ✓ | 4.7 |
| FreeStyle Libre 3 Plus | 7.9% | 15 days | Real time CGM | Yes | $15–$30 per month | $75–$150 per month | ✓ | 4.7 |
| Eversense 365 | 8.5% | 365 days | Real time CGM | Yes | $150–$350 per month (amortized including implant procedure) | $2,000–$5,000 per annual sensor cycle | — | 4.6 |
| Eversense E3 | 8.5% | 180 days | Real time CGM | Yes | $200–$400 per month (amortized including implant procedure) | $1,000–$3,000 per 6-month sensor cycle | — | 4.5 |
| FreeStyle Libre 2 | 9.2% | 14 days | Flash glucose monitoring (scan based with optional alarms) | Yes | $15–$30 per month | $75–$150 per month | ✓ | 4.4 |
| Dexcom Stelo | 9% | 15 days | Real time CGM | No | N/A — OTC product not covered by insurance | $49–$99 per month | — | 4.3 |
| Abbott Lingo | 9% | 14 days | Real time CGM | No | N/A — OTC product not covered by insurance | $49 per month | — | 4.2 |
| Medtronic Guardian 4 | 8.7% | 7 days | Real time CGM | Yes | $30–$50 per month | $200–$300 per month | ✓ | 4.2 |
| Abbott Libre Rio | 9% | 14 days | Real time CGM | No | N/A — OTC product not covered by insurance | $49 per month | — | 4.1 |
| SIBIONICS CGM | 9% | 14 days | Real time CGM | No | N/A — not yet available in US insurance networks | $30–$60 per month (international pricing) | — | 3.8 |